Brockel B - Search Results

1

Synthesis and SAR of aminothiazole fused benzazepines as selective dopamine D2 partial agonists.

Urbanek RA, Xiong H, Wu Y, Blackwell W, Steelman G, Rosamond J, Wesolowski SS, Campbell JB, Zhang M, Brockel B, Widzowski DV. Urbanek RA, et al. Among authors: brockel b. Bioorg Med Chem Lett. 2013 Jan 15;23(2):543-7. doi: 10.1016/j.bmcl.2012.11.023. Epub 2012 Nov 28. Bioorg Med Chem Lett. 2013. PMID: 23237836

2

4-aryl piperazine and piperidine amides as novel mGluR5 positive allosteric modulators.

Xiong H, Brugel TA, Balestra M, Brown DG, Brush KA, Hightower C, Hinkley L, Hoesch V, Kang J, Koether GM, McCauley JP Jr, McLaren FM, Panko LM, Simpson TR, Smith RW, Woods JM, Brockel B, Chhajlani V, Gadient RA, Spear N, Sygowski LA, Zhang M, Arora J, Breysse N, Wilson JM, Isaac M, Slassi A, King MM. Xiong H, et al. Among authors: brockel b. Bioorg Med Chem Lett. 2010 Dec 15;20(24):7381-4. doi: 10.1016/j.bmcl.2010.10.036. Epub 2010 Oct 21. Bioorg Med Chem Lett. 2010. PMID: 21067920

3

Preclinical pharmacology and pharmacokinetics of AZD3783, a selective 5-hydroxytryptamine 1B receptor antagonist.

Zhang M, Zhou D, Wang Y, Maier DL, Widzowski DV, Sobotka-Briner CD, Brockel BJ, Potts WM, Shenvi AB, Bernstein PR, Pierson ME. Zhang M, et al. Among authors: brockel bj. J Pharmacol Exp Ther. 2011 Nov;339(2):567-78. doi: 10.1124/jpet.110.174433. Epub 2011 Aug 8. J Pharmacol Exp Ther. 2011. PMID: 21825000 Clinical Trial.

4

In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.

Zysk JR, Spear N, Fieles W, Stein MM, Sygowski LS, King MM, Hoesch V, Hastings R, Brockel B, Do M, Ström P, Gadient R, Chhajlani V, Elmore CS, Maier DL. Zysk JR, et al. Among authors: brockel b. Synapse. 2013 Mar;67(3):135-44. doi: 10.1002/syn.21625. Epub 2012 Dec 6. Synapse. 2013. PMID: 23150216

5

Effects of chronic haloperidol on reaction time and errors in a sustained attention task: partial reversal by anticholinergics and by amphetamine.

Brockel BJ, Fowler SC. Brockel BJ, et al. J Pharmacol Exp Ther. 1995 Dec;275(3):1090-8. J Pharmacol Exp Ther. 1995. PMID: 8531068

6

Lead-induced decrements in waiting behavior: involvement of D2-like dopamine receptors.

Brockel BJ, Cory-Slechta DA. Brockel BJ, et al. Pharmacol Biochem Behav. 1999 Jul;63(3):423-34. doi: 10.1016/s0091-3057(99)00033-7. Pharmacol Biochem Behav. 1999. PMID: 10418784

7

Nucleus accumbens dopaminergic medication of fixed interval schedule-controlled behavior and its modulation by low-level lead exposure.

Cory-Slechta DA, O'Mara DJ, Brockel BJ. Cory-Slechta DA, et al. Among authors: brockel bj. J Pharmacol Exp Ther. 1998 Aug;286(2):794-805. J Pharmacol Exp Ther. 1998. PMID: 9694936

8

Lead exposure and dorsomedial striatum mediation of fixed interval schedule-controlled behavior.

Cory-Slechta DA, Brockel BJ, O'Mara DJ. Cory-Slechta DA, et al. Among authors: brockel bj. Neurotoxicology. 2002 Sep;23(3):313-27. doi: 10.1016/s0161-813x(02)00059-1. Neurotoxicology. 2002. PMID: 12387360

9

Glutamate and dopamine in nucleus accumbens core and shell: sequence learning versus performance.

Bauter MR, Brockel BJ, Pankevich DE, Virgolini MB, Cory-Slechta DA. Bauter MR, et al. Among authors: brockel bj. Neurotoxicology. 2003 Mar;24(2):227-43. doi: 10.1016/S0161-813X(02)00167-5. Neurotoxicology. 2003. PMID: 12606295

10

Lead, attention, and impulsive behavior: changes in a fixed-ratio waiting-for-reward paradigm.

Brockel BJ, Cory-Slechta DA. Brockel BJ, et al. Pharmacol Biochem Behav. 1998 Jun;60(2):545-52. doi: 10.1016/s0091-3057(98)00023-9. Pharmacol Biochem Behav. 1998. PMID: 9632239 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15 results

Search Page